Spotlight
Clinical Role
Clinical
Supplement Spotlight
CE
Subscribe
Insights on Conjugate Pneumococcal Vaccines
The vaccination experts analyze the impact of currently approved pneumococcal vaccines on otitis media prevention and compare the newer conjugate vaccines (PCV15 and PCV20) to their predecessors in terms of strain coverage and clinical efficacy.
EP: 1.Symptomatology and Transmission of Pneumococcal Infection
EP: 2.Manifestation of Pneumococcal Disease in Adults
EP: 3.High-Risk Populations for Severe Pneumococcal Infection
EP: 4.Patient Burden Associated with Pneumococcal Disease
EP: 5.Vaccination Efforts to Mitigate Pneumococcal Outbreaks
EP: 6.Comparing and Contrasting the Characteristics of the FDA-Approved Pneumococcal Vaccines
EP: 7.Target Patient Populations for Pneumococcal Vaccines
EP: 8.ACIP Recommendations for Pneumococcal Vaccination
EP: 9.Clinical Considerations for Pneumococcal Vaccination Scheduling
EP: 10.Clinical Data Supporting Pneumococcal Vaccination
Now Viewing
EP: 11.Insights on Conjugate Pneumococcal Vaccines
EP: 12.Future Considerations for Pneumococcal Vaccination
EP: 13.Barriers to Administering Pneumococcal Vaccines and Best Practices for Overcoming Them
EP: 14.Optimizing Pneumococcal Vaccination Efforts in High-Risk Patients
EP: 15.Closing Thoughts From The Panel On Pneumococcal Vaccination
- What effect do currently approved pneumococcal vaccines have on preventing otitis media?
- How do the newer conjugate vaccines (PCV15 and PCV20) compare to their predecessors in terms of strain coverage and clinical efficacy?
- What are your considerations for selecting between conjugate vaccines for adult patients who are vaccine-naïve?
- When would you use PCV20 instead of PCV15 and vice versa?
Recent Videos
Related Content
